रैंकिंग पर वापस जाएं

BrightSpring Health Services, Inc. (BTSG)

NEUTRAL
HealthcareHealth Information ServicesUnited States

Fundamental

67

मूल्य

$57.81

मार्केट कैप

$11.62B

भाग 1 · कंपनी का मूल्य कितना है

अवलोकन

BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States. The company operates through two segments, Pharmacy Solutions and Provider Services. Its platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It also offers infused, injectable, and oral medication services; and patient-centric, highly skilled, and compassionate clinical home health care, as well as rehabilitation services, including physical, speech and occupational therapy and applied behavioral analysis. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.

No editorial profile for this company yet

Direct competitors

Who this company fights with for the same customers

No editorial profile for this company yet

No competitor list for this company yet.

बैलेंस शीट और तरलता

राजस्व

$14.37B

पिछले 12 महीने (30/6/2026 तक)

शुद्ध आय

$366M

पिछले 12 महीने (30/6/2026 तक)

Free Cash Flow

$395M

कुल इक्विटी

$1.88B

कुल देनदारियाँ

$4.53B

Current Ratio

1.59

Interest Coverage

2.94

Debt/EBITDA

5.20

Earnings Per Share

राजस्व और शुद्ध आय

Free Cash Flow

आय विवरण

ऐतिहासिक विवरण

समय के साथ मार्जिन

समय के साथ ऋण

ऋण कितना भारी है

वृद्धि तालिका

वृद्धि — राजस्व

Fair Value अनुमान

उचित मूल्यांकित

Fair Value

$71.31

वर्तमान मूल्य

$57.81

Margin of Safety

+18.9%

Fair Value सीमा

$56.87 - $85.75

अनुमान विधियाँ

Analyst Target:$78.94
DCF:$79.89
PE-based:$41.90
Graham Growth:$57.66
EPV:$10.86
विश्लेषक सहमति:दृढ़ खरीदें (24B / 1H / 0S)
अंतिम Earnings सरप्राइज़:+11.22%

मूल्यांकन मेट्रिक्स

P/E Ratio

36.05

ROE

10.2%

P/B Ratio

5.75

P/FCF

29.26

Gross Margin

12.4%

ROIC

8.0%

लाभप्रदता Radar

Value Creation (Economic Moat)

ROIC

8.0%

WACC

13.2%

ROIC − WACC

-5.2 pp

ROIC is below the cost of capital — the company is destroying value for every dollar invested.

Fundamental विश्लेषण मानदंड

पास (18)

  • EPS shows upward trend
  • Price CAGR 86.00%
  • ROIC 8.0%
  • P/FCF 29.26
  • Debt/Equity ratio
  • Positive Free Cash Flow
  • Current Ratio
  • Interest Coverage
  • Debt/EBITDA
  • Return on Tangible Assets
  • ROE 19.0%
  • Revenue Growth 5Y 18.3%
  • Analyst Consensus 96% Buy
  • Earnings Surprise avg 17.2%
  • PEG Ratio 0.68
  • Earnings Quality (OCF/NI) 1.38
  • Net Margin Trend 2.5% vs 0.6%
  • Piotroski F-Score 7/9

फेल (8)

  • Gross Margin 12.4%
  • P/B Ratio 5.75
  • Operating Margin 3.1%
  • CapEx intensity
  • Low reliance on intangibles
  • Price below Graham Number
  • DCF valuation (Overvalued)
  • Share Dilution 9.2%

अनुपलब्ध (1)

  • Dividend Payout NaN%

Piotroski F-Score

7/9

मजबूत वित्तीय स्वास्थ्य

score
criteria

Earnings गुणवत्ता

1.38

उच्च गुणवत्ता: earnings नकदी द्वारा समर्थित

शेयर Dilution

9.2%

नए शेयर जारी कर रही है, स्वामित्व को कम कर रही है

प्रशासन

कार्यकारी टीम

नामपदआयु
Mr. Jon B. RousseauChairman, President & CEO51
Ms. Jennifer A. PhippsCFO, Executive VP & Corporate Secretary44
Ms. Lisa NalleyChief of Staff & Senior VP of Human Resources52
Ms. Jennifer YowlerSenior VP of Sales & Account Management - PharMerica48
Mr. Scott Greenwell Pharm.D.Executive VP & President of PharMerica-
Mr. Charles H. WardripChief Information Officer-

Audit जोखिम

7

बोर्ड जोखिम

9

मुआवजा जोखिम

8

शेयरधारक अधिकार जोखिम

8

भाग 2 · कीमत और खरीदने का समय

यह हिस्सा यह नहीं बताता कि कंपनी अच्छी है या नहीं: यह तय करने में मदद करता है कि उसे कब खरीदें, जब फंडामेंटल आपको आश्वस्त कर चुके हों। इसमें: तकनीकी विश्लेषण, संभावना, ऐतिहासिक गिरावट, गामा एक्सपोज़र।

Latest News

Recent headlines for BTSG, sourced from Markets Gazette.

  • 2/27/2026NEUTRAL
    BrightSpring (BTSG) Earnings Call Transcript

    Markets Gazette reports that BrightSpring Health Services, Inc. (BTSG) held its earnings call on February 27, 2026. However, the detailed content of the transcript is not yet publicly available. Without access to specific financial data, future guidance, or management commentary, investors lack concrete elements to assess the company's performance or outlook. The absence of information prevents a clear directional analysis, leaving the stock in a holding pattern. The market will remain in suspense until the details are published, which could then trigger significant movements once key data points are released.

via Markets Gazette

Disclaimer

यह प्लेटफ़ॉर्म केवल शैक्षिक उद्देश्यों के लिए है। यह कोई वित्तीय, निवेश, या ट्रेडिंग सलाह नहीं देता। सभी स्कोर, मूल्यांकन, और संकेत सार्वजनिक रूप से उपलब्ध डेटा के स्वचालित विश्लेषण पर आधारित हैं जो अधूरे या गलत हो सकते हैं। निवेश निर्णय लेने से पहले हमेशा अपना शोध करें और एक योग्य वित्तीय सलाहकार से परामर्श लें।

निर्मित द्वारा CODEPRESS s.r.l.